{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:32:38Z","timestamp":1753893158238,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005624","name":"Hannover Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>Subclinical graft injuries in orthotopic liver transplantation may threaten long-term graft survival and could be the result of chronic under-immunosuppression. It is not known whether steroid withdrawal increases the risk of subclinical immune responses against the graft. This retrospective single-center study aimed to assess the risk of subclinical graft damage after steroid withdrawal within the first nine months after orthotopic liver transplantation in the first three years after transplantation in a prospective cohort of surveillance biopsies using a propensity score matching analysis. Of 355 patients, 109 patients underwent surveillance biopsies between eleven and 36 months after liver transplantation. Thirty-seven patients discontinue steroids within the first nine months and 72 later than nine months after transplantation. The matching led to 28 patients per group. Patients with autoimmune hepatitis, primary biliary cholangitis, and hepatocarcinoma were excluded by the propensity score matching unintentionally. Patients who discontinued steroids had a trend toward lower levels of immunosuppression at the time of surveillance biopsy. Steroid withdrawal in the first nine months was not associated with an increased risk of subclinical T cell-mediated rejection, graft inflammation, or liver graft fibrosis in the matched cohort with patients with a low frequency of autoimmune liver diseases. There were also no differences in the development of metabolic diseases. In conclusion, steroid withdrawal within the first nine months after transplantation, as assessed by surveillance biopsies, does not increase the risk of subclinical graft injuries or fibrosis at least in liver transplant recipient without or a low prevalence of autoimmune liver diseases.<\/jats:p>","DOI":"10.3389\/frtra.2023.1124551","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:46:51Z","timestamp":1677052011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of steroid withdrawal on subclinical graft injury after liver transplantation: A propensity score-matched cohort analysis"],"prefix":"10.3389","volume":"2","author":[{"given":"Alejandro","family":"Campos-Murguia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Bosselmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Hartleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastian","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Jaeckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1002\/lt.24840","article-title":"Liver transplantation: rejection and tolerance","volume":"23","author":"Taner","year":"2017","journal-title":"Liver Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00001","article-title":"Transplant tolerance induction: insights from the liver","volume":"11","author":"Dai","year":"2020","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/hep.1840020516","article-title":"Evolution of liver transplantation","volume":"2","author":"Starzl","year":"1982","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects after renal transplantation","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/lt.20291","article-title":"Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study","volume":"10","author":"Pageaux","year":"2004","journal-title":"Liver Transpl"},{"key":"B6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/ctr.12119","article-title":"Completely steroid-free immunosuppression in liver transplantation: a randomized study","volume":"27","author":"Ramirez","year":"2013","journal-title":"Clin Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/hep.510270609","article-title":"Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial","volume":"27","author":"Belli","year":"1998","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"CD007606","DOI":"10.1002\/14651858.CD007606.pub4","article-title":"Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients","volume":"12","author":"Fairfield","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jhep.2018.04.012","article-title":"Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients","volume":"69","author":"Londo\u00f1o","year":"2018","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-70938-7","article-title":"Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies","volume":"10","author":"H\u00f6fer","year":"2020","journal-title":"Sci Reports"},{"key":"B11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ajt.16817","article-title":"Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation","volume":"22","author":"Saunders","year":"2022","journal-title":"Am J Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.jhep.2021.08.007","article-title":"Non-invasive alloimmune risk stratification of long-term liver transplant recipients","volume":"75","author":"Vionnet","year":"2021","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/TP.0000000000003034","article-title":"DSA are associated with more graft injury, more fibrosis, and upregulation of rejection-associated transcripts in subclinical rejection","volume":"104","author":"H\u00f6fer","year":"2020","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/lt.24427","article-title":"Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts","volume":"22","author":"Baumann","year":"2016","journal-title":"Liver Transpl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"Comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"2016","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1111\/j.1600-6143.2012.04210.x","article-title":"Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children","volume":"12","author":"Venturi","year":"2012","journal-title":"Am J Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"Matchit: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"B23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine a protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.30031","article-title":"The impact of autoimmune hepatitis and its treatment on health utility","volume":"68","author":"Wong","year":"2018","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/lt.26399","article-title":"Clinical value of surveillance biopsies in pediatric liver transplantation","volume":"28","author":"Rocque","year":"2022","journal-title":"Liver Transpl"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2023.1124551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:46:54Z","timestamp":1677052014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2023.1124551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":25,"alternative-id":["10.3389\/frtra.2023.1124551"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2023.1124551","relation":{},"ISSN":["2813-2440"],"issn-type":[{"type":"electronic","value":"2813-2440"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"article-number":"1124551"}}